Literature DB >> 2706190

Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.

E J Van Hoogdalem1, A T Wackwitz, A G De Boer, A F Cohen, D D Breimer.   

Abstract

1. The effects of sodium octanoate and sodium salicylate on the rectal absorption of cefoxitin were investigated in healthy volunteers. Drug solutions were given either as a bolus or as a zero-order infusion. 2. On rectal infusion sodium octanoate and sodium salicylate both enhanced mean cefoxitin bioavailability (+/- s.d.) from 5.0 +/- 1.2% to 9.1 +/- 1.3% and 9.2 +/- 1.5%, respectively. After rectal bolus delivery octanoate increased the mean cefoxitin bioavailability from 7 +/- 3% to 17 +/- 3%, whereas bolus salicylate did not produce a statistically significant effect. All formulations were well tolerated by the volunteers. 3. It is concluded that both octanoate and salicylate are capable of enhancing rectal cefoxitin absorption in man; rate of delivery seems to be an important factor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706190      PMCID: PMC1379707          DOI: 10.1111/j.1365-2125.1989.tb05337.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.

Authors:  G Levy; J A Procknal
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

2.  Studies on the promoting effects of carboxylic acid derivatives on the rectal absorption of beta-lactam antibiotics in rats.

Authors:  K Nishimura; Y Nozaki; A Yoshimi; S Nakamura; M Kitagawa; N Kakeya; K Kitao
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-01       Impact factor: 1.645

3.  Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: concentration-effect relationship.

Authors:  E J van Hoogdalem; M A Hardens; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

4.  Use of adjuvants for enhancement of rectal absorption of cefoxitin in humans.

Authors:  S S Davis; W R Burnham; P Wilson; J O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Improvement of bioavailability of poorly absorbed drugs. II. Effect of medium chain glyceride base on the intestinal absorption of cefmetazole sodium in rats and dogs.

Authors:  M Sekine; H Terashima; K Sasahara; K Nishimura; R Okada; S Awazu
Journal:  J Pharmacobiodyn       Date:  1985-04

6.  Enhancement of the rectal absorption of sodium ampicillin by N-acylamino acids in rats.

Authors:  W M Wu; T Murakami; Y Higashi; N Yata
Journal:  J Pharm Sci       Date:  1987-07       Impact factor: 3.534

7.  Effect of triglyceride on small intestinal absorption of cefoxitin in rats.

Authors:  H Yoshitomi; T Nishihata; G Frederick; M Dillsaver; T Higuchi
Journal:  J Pharm Pharmacol       Date:  1987-11       Impact factor: 3.765

8.  Rate-controlled absorption enhancement of rectally administered cefazolin in rats by a glyceride mixture (MGK).

Authors:  E J van Hoogdalem; A M Stijnen; A G de Boer; D D Breimer
Journal:  J Pharm Pharmacol       Date:  1988-05       Impact factor: 3.765

9.  Enhanced small intestinal absorption of beta-lactam antibiotics in rats in the presence of monodesmosides isolated from pericarps of Sapindus mukurossi (Enmei-hi).

Authors:  N Yata; N Sugihara; R Yamajo; T Murakami; Y Higashi; H Kimata; K Nakayama; T Kuzuki; O Tanaka
Journal:  J Pharmacobiodyn       Date:  1986-02

10.  Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract.

Authors:  J A Fix; K Engle; P A Porter; P S Leppert; S J Selk; C R Gardner; J Alexander
Journal:  Am J Physiol       Date:  1986-09
View more
  1 in total

Review 1.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.